AIDS research. IOM panel clears HIV prevention study.
Couzin
Jennifer
J
D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000592:standards; D005260:Female; D015658:HIV Infections / Q000188:drug therapy / Q000517:prevention & control* / Q000635:transmission*; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D015969:National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division; D009316:National Institutes of Health (U.S.); D019829:Nevirapine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010865:Pilot Projects; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D014454:Uganda; D014481:United States
D019380:Anti-HIV Agents; D019829:Nevirapine